Symbol
| SERPINB5
| contributors: mct/pgu - updated : 30-04-2010
|
HGNC name
| serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
HGNC id
| 8949
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| deletion
|  
|  
|
frequently in advanced cancer with metastases | tumoral
|  
|  
| --over
|  
|
in high-grade prostate intraepithelial neoplasia (HGPIN) | tumoral
|  
|  
| --low
|  
|
by hypermethylation in papillary thyroid carcinomas | tumoral
|  
|  
| --over
|  
|
in lung cancer (squamous cell carcinomas) and in preneoplastic bronchial lesions | tumoral
|  
|  
| --over
|  
|
by hypomethylation in a large fraction of pancreatic cancer cell lines and primary pancreatic carcinomas | |
Variant & Polymorphism
|
| |
Candidate gene
| increased expression of SERPINB5 is associated with metastasis of hepatocellular carcinoma |
|
detection of SERPINB5 in blood may indicate aggressive disease in breast cancer |
Marker
| may be a useful marker to identify the potential for progression in oral squamous cell carcinoma |
|
cytoplasmic mSERPINB5 may play an important role in lung carcinomas by regulating apoptosis and thus is a favorable prognostic marker for adenocarcinoma patients whereas nuclear localization may be linked to promotion of angiogenesis |
Therapy target
| |